Salud

Johnson & Johnson jurors ruled Tuesday that the company must pay $15 million to a Connecticut resident who claims he developed mesothelioma, a rare form

British drugmaker GlaxoSmithKline sued Moderna in a US federal court in Delaware, accusing the company of infringing GSK’s patent rights to GSK’s information RNA technology

UnitedHealth Group on Tuesday reported a sharp rise in health care costs in the third quarter as it struggled to cope with declining government reimbursements

Bayer on Tuesday said it has applied to the European Medicines Agency (EMA) for marketing authorisation for its menopause symptom relief drug elinzanetant. A third

The UK will examine whether an Eli Lilly weight-loss drug could put people back to work and help tackle the high levels of chronic illness

Pfizer and its partner BioNTech won their bid to invalidate CureVac’s COVID vaccine patents in the High Court in London. Pfizer and BioNTech had filed

European Commission authorises Novavax The company said Wednesday it has updated its COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region. The authorisation

Australia and New Zealand are preparing for the emergence of a devastating strain of bird flu by tightening biosecurity measures on farms, testing shorebirds for

Johnson & Johnson said on Monday it was halting a final-stage study of its experimental drug to treat a type of bladder cancer because the

Danish Zealand Pharma and German partner Boehringer Ingelheim have won the US Food and Drug Administration’s Breakthrough Therapy competition to review their experimental weight-loss drug